Get the Stockscreener App
16.68
0.54%
-0.075
Sionna Therapeutics Inc stock is traded at $16.68, with a volume of 8,147.
It is down -0.54% in the last 24 hours and down -8.20% over the past month.
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
See More
Previous Close:
$16.76
Open:
$16.44
24h Volume:
8,147
Relative Volume:
0.05
Market Cap:
$735.11M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-12.72%
1M Performance:
-8.20%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$16.38
$16.89
1-Week Range:
$16.38
$20.55
52-Week Range:
$7.255
$24.90
Sionna Therapeutics Inc Stock (SION) Company Profile
Name
Sionna Therapeutics Inc
Sector
Industry
Phone
617-819-2020
Address
21 HICKORY DRIVE, SUITE 500, WALTHAM
Compare SION with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
16.66 | 782.64M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.37 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
395.42 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
667.14 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.49 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Initiated | Guggenheim | Buy |
| Mar-04-25 | Initiated | Stifel | Buy |
| Mar-04-25 | Initiated | TD Cowen | Buy |
Sionna Therapeutics Inc Stock (SION) Latest News
Intrinsic Value of Sionna Therapeutics Inc. Stock: Is It Undervalued or OvervaluedFree Triple Return Setup with Risk Control - Newser
What makes Sionna Therapeutics Inc. stock price move sharplyInvestment Timeline and ROI Summary Report - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionFree Triple Return Setup with Risk Control - Newser
What is the risk reward ratio of investing in Sionna Therapeutics Inc. stockAI Powered Forecasts With Proven Results - jammulinksnews.com
What earnings revisions data tells us about Sionna Therapeutics Inc.Entry Opportunity Screener with Confirmation - Newser
Automated trading signals detected on Sionna Therapeutics Inc.Conservative Asset Allocation Risk Analysis - Newser
What’s next for Sionna Therapeutics Inc. stock priceFree High Conviction Intraday Stock Signals - Newser
Key resistance and support levels for Sionna Therapeutics Inc.Short Term Momentum Based Trading Strategy - Newser
Can swing trading help recover from Sionna Therapeutics Inc. lossesOversold Opportunity Scanner with RSI Data - Newser
Is Sionna Therapeutics Inc. trending in predictive chart modelsAI Screener for Daily Stock Forecast - Newser
Sionna Therapeutics, Inc.’s Lock-Up Period To Expire on August 6th (NASDAQ:SION) - Defense World
Venture Co. Limited (OTCMKTS:VEMLY) Short Interest Update - Defense World
MACD Cross Could Confirm Trend in Sionna Therapeutics Inc.High Yield Stock Screening Results Explained - metal.it
Published on: 2025-07-29 22:11:07 - metal.it
Published on: 2025-07-29 13:11:50 - metal.it
Published on: 2025-07-28 23:06:16 - metal.it
Is it the right time to buy Sionna Therapeutics Inc. stockAchieve fast wealth growth with smart picks - jammulinksnews.com
Here's Why We're Not Too Worried About Sionna Therapeutics' (NASDAQ:SION) Cash Burn Situation - Yahoo Finance
How strong is Sionna Therapeutics Inc. company’s balance sheetStock Market Opportunities For Beginners - jammulinksnews.com
How volatile is Sionna Therapeutics Inc. stock compared to the marketFree Stock Chart Pattern Guide - jammulinksnews.com
Does Sionna Therapeutics Inc. stock perform well during market downturnsDiscover stocks with superior performance - jammulinksnews.com
Should I hold or sell Sionna Therapeutics Inc. stock in 2025Harness the power of proven investment plans - jammulinksnews.com
Is Sionna Therapeutics Inc. a growth stock or a value stockFree Market Volatility Navigation Tips - jammulinksnews.com
Why is Sionna Therapeutics Inc. stock attracting strong analyst attentionFree Stock Market Mentorship - jammulinksnews.com
What is the dividend policy of Sionna Therapeutics Inc. stockGet real-time alerts on high-potential stocks - jammulinksnews.com
Is Sionna Therapeutics Inc. stock overvalued or undervaluedOutstanding capital appreciation - jammulinksnews.com
What catalysts could drive Sionna Therapeutics Inc. stock higher in 2025Get real-time alerts on high-potential stocks - jammulinksnews.com
Will Sionna Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsAlpha Stock Ideas - Newser
How Resilient Is LPTX Stock During Economic DownturnsDaily Breakout Picks - Newser
Sionna Therapeutics Inc Stock (SION) Financials Data
There is no financial data for Sionna Therapeutics Inc (SION). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Sionna Therapeutics Inc Stock (SION) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| TPG GP A, LLC | 10% Owner |
Feb 10 '25 |
Buy |
18.00 |
1,125,000 |
20,250,000 |
6,684,962 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Feb 10 '25 |
Buy |
18.00 |
1,125,000 |
20,250,000 |
6,923,365 |
| ORBIMED ADVISORS LLC | Director |
Feb 10 '25 |
Buy |
18.00 |
550,000 |
9,900,000 |
3,704,959 |
| Thompson Peter A. | Director |
Feb 10 '25 |
Buy |
18.00 |
550,000 |
9,900,000 |
3,704,959 |
| Booth Bruce | Director |
Feb 10 '25 |
Buy |
18.00 |
60,000 |
1,080,000 |
807,727 |
| Atlas Venture Fund XI, L.P. | 10% Owner |
Feb 10 '25 |
Buy |
18.00 |
60,000 |
1,080,000 |
807,727 |
0.40%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):